NRF2-Associated ROS Clearance by PRP-TPGN Hydrogel Accelerates Re-Epithelialization in Diabetic Wounds.
Lin Jieru, Fan Yahan, Sun Rongwan, Zhang Pengrui, Zhu Mingyu, Li Shiyao, Peng Guiliang, Tang Zini, Liu Jie, Cheng Liqing, Zhou Ling, Li Lanlan, Xu Tailin, Long Min
Abstract
In the diabetic wound microenvironment, excessive accumulation of reactive oxygen species (ROS) induces severe oxidative stress, thereby restricting re-epithelialization. Although platelet-rich plasma (PRP) gel can promote tissue repair by releasing platelet-derived growth factor (PDGF) and vascular endothelial growth factor (VEGF), its bioactivity is substantially degraded by high ROS levels, which limits its clinical utility. To address this challenge, we designed a glucose-based molecular scaffold covalently conjugated with 4-Hydroxy-2,2,6,6-tetramethylpiperidin-1-oxyl (Tempol) and phenylboronic acid pinacol ester (PBAP), designated TPG. This molecule spontaneously self-assembles into monodisperse spherical nanoparticles (TPG-PBAP-Glucose nanoparticles, TPGN), which exhibit favorable biocompatibility and H2O2-triggered degradation, enabling on-demand payload release within oxidative microenvironments. We further incorporated TPGN into PRP to form an in situ forming PRP-TPGN composite gel. In vitro functional assays demonstrated that this composite gel accelerated keratinocyte migration under high-glucose conditions by activating the nuclear factor erythroid 2-related factor 2 (NRF2) antioxidant signaling pathway; this protective effect was markedly attenuated by NRF2 knockdown or pharmacological inhibition. In streptozotocin-induced diabetic mice, PRP-TPGN expedited wound closure through NRF2-mediated ROS clearance, and this therapeutic benefit was largely diminished in NRF2-knockout animals. Collectively, the PRP-TPGN hydrogel constitutes a rationally designed, redox-synergistic therapeutic platform for the targeted management of refractory diabetic cutaneous ulcers.
Key Findings
- The PRP-TPGN composite gel accelerates keratinocyte migration under high-glucose conditions by activating the NRF2 antioxidant signaling pathway.
- The therapeutic effect of the PRP-TPGN gel is significantly reduced by NRF2 knockdown or pharmacological inhibition, indicating NRF2's critical role.
- In diabetic mice, PRP-TPGN hydrogel expedites wound closure through NRF2-mediated ROS clearance, with diminished benefits observed in NRF2-knockout animals.
Clinical Significance
The PRP-TPGN hydrogel offers a novel redox-responsive therapeutic strategy to enhance diabetic wound healing by activating NRF2-dependent antioxidant defenses, addressing the challenge of oxidative stress in refractory diabetic ulcers.
Citation
Lin Jieru, Fan Yahan, Sun Rongwanet al.. NRF2-Associated ROS Clearance by PRP-TPGN Hydrogel Accelerates Re-Epithelialization in Diabetic Wounds. Advanced science (Weinheim, Baden-Wurttemberg, Germany). 2026-Nov-15.